Learn About Paramyotonia Congenita

What is the definition of Paramyotonia Congenita?

Paramyotonia congenita is a disorder that affects muscles used for movement (skeletal muscles). Beginning in infancy or early childhood, people with this condition experience bouts of sustained muscle tensing (myotonia) that prevent muscles from relaxing normally. Myotonia causes muscle stiffness that typically appears after exercise and can be induced by muscle cooling. This stiffness chiefly affects muscles in the face, neck, arms, and hands, although it can also affect muscles used for breathing and muscles in the lower body. Unlike many other forms of myotonia, the muscle stiffness associated with paramyotonia congenita tends to worsen with repeated movements.

What are the causes of Paramyotonia Congenita?

Mutations in the SCN4A gene cause paramyotonia congenita. This gene provides instructions for making a protein that is critical for the normal function of skeletal muscle cells. For the body to move normally, skeletal muscles must tense (contract) and relax in a coordinated way. Muscle contractions are triggered by the flow of positively charged atoms (ions), including sodium, into skeletal muscle cells. The SCN4A protein forms channels that control the flow of sodium ions into these cells.

How prevalent is Paramyotonia Congenita?

Paramyotonia congenita is an uncommon disorder; it is estimated to affect fewer than 1 in 100,000 people.

Is Paramyotonia Congenita an inherited disorder?

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In many cases, an affected person has one parent with the condition.

Who are the top Paramyotonia Congenita Local Doctors?

Fairview Express Care

6545 France Ave S, Suite 450, 
Edina, MN 
 (92.5 mi)
Languages Spoken:
English, Greek
Accepting New Patients

Georgios Manousakis is a Neurologist in Edina, Minnesota. Dr. Manousakis and is rated as a Distinguished provider by MediFind in the treatment of Paramyotonia Congenita. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Myotonic Dystrophy Type 2, Myotonic Dystrophy, and Paramyotonia Congenita. Dr. Manousakis is currently accepting new patients.

Child and Adolescent Psychiatry | Pediatrics | Psychiatry
Child and Adolescent Psychiatry | Pediatrics | Psychiatry

University Of Minnesota Health Clinics And Surgery Center Inc

909 Fulton St Se, 
Minneapolis, MN 
 (98.1 mi)
Languages Spoken:
English, Russian
Accepting New Patients
Offers Telehealth

Peter Karachunski is a Child and Adolescent Psychiatrist and a Pediatrics provider in Minneapolis, Minnesota. Dr. Karachunski and is rated as a Distinguished provider by MediFind in the treatment of Paramyotonia Congenita. His top areas of expertise are Duchenne Muscular Dystrophy, Paramyotonia Congenita, Myotonic Dystrophy Type 2, and Myotonic Dystrophy. Dr. Karachunski is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Family Medicine
Family Medicine

Centracare Clinic

200 W 1st St, Paynesville Area Medical Clinic, 
Paynesville, MN 
 (47.2 mi)
Languages Spoken:
English, Urdu
Accepting New Patients
Offers Telehealth

Randall Zimmerman is a Family Medicine provider in Paynesville, Minnesota. Dr. Zimmerman and is rated as an Experienced provider by MediFind in the treatment of Paramyotonia Congenita. His top areas of expertise are Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). Dr. Zimmerman is currently accepting new patients.

What are the latest Paramyotonia Congenita Clinical Trials?
Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2 (BraCE-DM2)

Summary: Nearly two-third of patients with myotonic dystrophy type 2 (DM2) report that impaired cognition is among the most disabling symptoms and deeply affects their quality of life. Yet, relatively little is known about how DM2 affects brain structure and cognitive function as brain imaging studies in DM2 are extremely limited. This is a prospective, cross-sectional study of brain structure and function...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Pelvic Floor Muscle Training for Urinary Incontinence in Women with Myotonic Dystrophy Type 1: a Feasibility and Acceptability Study

Summary: Myotonic dystrophy type 1 (DM1) is a neuromuscular disease characterized by multisystem manifestations. DM1 can affect the urinary system through the impact of the pelvic floor muscles (PFM). Urinary incontinence can occur in this situation and is often offset with compensatory measures without restoring the PFM function (e.g. sanitary pads). PFM training have already been shown to be effective in...

Who are the sources who wrote this article ?

Published Date: August 01, 2015
Published By: National Institutes of Health